| Angela Popp, MS CCC/SLP | |
|
600 York St, Manitowoc, WI 54220-6845 | |
| (920) 320-6750 | |
| (920) 682-1981 |
| Full Name | Angela Popp |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 600 York St, Manitowoc, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053330506 | NPI | - | NPPES |
| 42567300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2663-154 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Popp, MS CCC/SLP 2300 Western Ave, Po Box 2170, Manitowoc, WI 54220-3712 Ph: (920) 320-8667 | Angela Popp, MS CCC/SLP 600 York St, Manitowoc, WI 54220-6845 Ph: (920) 320-6750 |
News Archive
Under a settlement agreement reached with the U.S. Department of Health and Human Services, deaf patients at the Fort Washington Medical Center in Prince George's County, Md., will be screened and provided with sign language interpreters whenever interpreter services are necessary for effective communication.
Trastuzumab emtansine significantly delays disease progression compared with standard therapy in women with human epidermal growth factor receptor-2-positive metastatic breast cancer, show study data presented at the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, USA.
Researchers at Mayo Clinic have identified the enzyme, called CD38, that is responsible for the decrease in nicotinamide adenine dinucleotide (NAD) during aging, a process that is associated with age-related metabolic decline.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
› Verified 2 days ago
Rachelle Marie Pollen, MS CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 960 S Rapids Rd, Manitowoc, WI 54220 Phone: 920-684-1144 | |
Jennie Mccormick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-3100 | |
Lola Bridget Defever, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Western Ave, Manitowoc, WI 54220 Phone: 262-804-7554 | |
Hailey Elizabeth Boyer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Western Ave, Manitowoc, WI 54220 Phone: 920-684-2011 | |
Erica Ann Helein Jansky, MS-CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2021 S Alverno Rd, Manitowoc, WI 54220 Phone: 920-683-4108 | |
Paula Tenpas Johnson, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 York St, Manitowoc, WI 54220 Phone: 920-320-6850 Fax: 920-682-1981 |